1
|
Lu X, Zhong R, Hu L, Huang L, Chen L, Cheng W, Zheng B, Liang P. DHA-enriched phospholipids from large yellow croaker roe regulate lipid metabolic disorders and gut microbiota imbalance in SD rats with a high-fat diet. Food Funct 2021; 12:4825-4841. [PMID: 33949580 DOI: 10.1039/d1fo00747e] [Citation(s) in RCA: 12] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Abstract
Large yellow croaker roe phospholipids (LYCRPLs) have great nutritional value because they are rich in docosahexaenoic acid (DHA), which is an n-3 polyunsaturated fatty acid (n-3 PUFA). In previous research, we studied the effect of LYCRPLs on the inhibition of triglyceride accumulation at the cellular level. However, its lipid regulation effect in rats on a high-fat diet and its influence on the gut microbiota has not yet been clarified. In this study, a high-fat diet was used to induce the lipid metabolism disorder in SD rats, and simvastatin, low-dose, medium-dose and high-dose LYCRPLs were given by intragastric administration for 8 weeks. The rats' body weight, food intake, organ index, blood biochemical indicators, epididymal fat tissue and liver histopathology were compared and analyzed. High-throughput 16S rRNA gene sequencing technology and bioinformatics analysis technology were also used to analyze the diversity of gut microbiota in rats. We found that LYCRPLs can significantly regulate lipid metabolism, and improve the gut microbiota disorder induced in rats by a high-fat diet. These results can lay a foundation for the study of the regulation mechanism of LYCRPLs lipid metabolism, and also provide a theoretical basis for the development of LYCRPLs as functional food additives and excipients with hypolipidemic effects.
Collapse
Affiliation(s)
- Xiaodan Lu
- Engineering Research Centre of Fujian-Taiwan Special Marine Food Processing and Nutrition, Ministry of Education, Fuzhou, 350002, Fujian, P.R. China. and College of Food Science, Fujian Agriculture and Forestry University, Fuzhou, 350002, Fujian, P.R. China and Fujian Provincial Key Laboratory of Quality Science and Processing Technology in Special Starch, Fujian Agriculture and Forestry University, Fuzhou, 350002, Fujian, P.R. China
| | - Rongbin Zhong
- College of Food Science, Fujian Agriculture and Forestry University, Fuzhou, 350002, Fujian, P.R. China
| | - Ling Hu
- College of Food Science, Fujian Agriculture and Forestry University, Fuzhou, 350002, Fujian, P.R. China
| | - Luyao Huang
- College of Food Science, Fujian Agriculture and Forestry University, Fuzhou, 350002, Fujian, P.R. China
| | - Lijiao Chen
- College of Food Science, Fujian Agriculture and Forestry University, Fuzhou, 350002, Fujian, P.R. China
| | - Wenjian Cheng
- College of Food Science, Fujian Agriculture and Forestry University, Fuzhou, 350002, Fujian, P.R. China
| | - Baodong Zheng
- Engineering Research Centre of Fujian-Taiwan Special Marine Food Processing and Nutrition, Ministry of Education, Fuzhou, 350002, Fujian, P.R. China. and College of Food Science, Fujian Agriculture and Forestry University, Fuzhou, 350002, Fujian, P.R. China and Fujian Provincial Key Laboratory of Quality Science and Processing Technology in Special Starch, Fujian Agriculture and Forestry University, Fuzhou, 350002, Fujian, P.R. China
| | - Peng Liang
- Engineering Research Centre of Fujian-Taiwan Special Marine Food Processing and Nutrition, Ministry of Education, Fuzhou, 350002, Fujian, P.R. China. and College of Food Science, Fujian Agriculture and Forestry University, Fuzhou, 350002, Fujian, P.R. China
| |
Collapse
|
2
|
Lobos Bejarano JM, Galve E, Royo-Bordonada MÁ, Alegría Ezquerra E, Armario P, Brotons Cuixart C, Camafort Babkowski M, Cordero Fort A, Maiques Galán A, Mantilla Morató T, Pérez Pérez A, Pedro-Botet J, Villar Álvarez F, González-Juanatey JR. Posicionamiento del Comité Español Interdisciplinario de Prevención Cardiovascular y la Sociedad Española de Cardiología en el tratamiento de las dislipemias. Divergencia entre las guías europea y estadounidense. ANGIOLOGIA 2015. [DOI: 10.1016/j.angio.2014.09.016] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
3
|
Comments on the ESC/ESH guidelines for the management of arterial hypertension 2013. A report of the Task Force of the Clinical Practice Guidelines Committee of the Spanish Society of Cardiology. ACTA ACUST UNITED AC 2015; 66:842-7. [PMID: 24773990 DOI: 10.1016/j.rec.2013.08.003] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/10/2013] [Accepted: 08/13/2013] [Indexed: 10/26/2022]
|
4
|
Posicionamiento del Comité Español Interdisciplinario de Prevención Cardiovascular y la Sociedad Española de Cardiología en el tratamiento de las dislipemias. Divergencia entre las guías europea y estadounidense. HIPERTENSION Y RIESGO VASCULAR 2015; 32:83-91. [DOI: 10.1016/j.hipert.2014.09.002] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/07/2014] [Accepted: 09/16/2014] [Indexed: 11/17/2022]
|
5
|
Posicionamiento del Comité Español Interdisciplinario de Prevención Cardiovascular y la Sociedad Española de Cardiología en el tratamiento de las dislipemias. Divergencia entre las guías europea y estadounidense. Semergen 2015; 41:149-57. [DOI: 10.1016/j.semerg.2014.05.020] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/24/2014] [Accepted: 05/21/2014] [Indexed: 11/21/2022]
|
6
|
|
7
|
Galve E, Cordero A, Bertomeu-Martínez V, Fácila L, Mazón P, Alegría E, Fernández de Bobadilla J, García-Porrero E, Martínez-Sellés M, González-Juanatey JR. Update in cardiology: vascular risk and cardiac rehabilitation. ACTA ACUST UNITED AC 2015; 68:136-43. [PMID: 25583549 DOI: 10.1016/j.rec.2014.10.005] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/16/2014] [Accepted: 10/02/2014] [Indexed: 01/03/2023]
Abstract
As in other fields, understanding of vascular risk and rehabilitation is constantly improving. The present review of recent epidemiological update shows how far we are from achieving good risk factor control: in diet and nutrition, where unhealthy and excessive societal consumption is clearly increasing the prevalence of obesity; in exercise, where it is difficult to find a balance between benefit and risk, despite systemization efforts; in smoking, where developments center on programs and policies, with the electronic cigarette seeming more like a problem than a solution; in lipids, where the transatlantic debate between guidelines is becoming a paradigm of the divergence of views in this extensively studied area; in hypertension, where a nonpharmacological alternative (renal denervation) has been undermined by the SYMPLICITY HTN-3 setback, forcing a deep reassessment; in diabetes mellitus, where the new dipeptidyl peptidase-4 and sodium-glucose cotransporter type 2 inhibitors and glucagon like peptide 1 analogues have contributed much new information and a glimpse of the future of diabetes treatment, and in cardiac rehabilitation, which continues to benefit from new information and communication technologies and where clinical benefit is not hindered by advanced diseases, such as heart failure. Our summary concludes with the update in elderly patients, whose treatment criteria are extrapolated from those of younger patients, with the present review clearly indicating that should not be the case.
Collapse
Affiliation(s)
- Enrique Galve
- Servicio de Cardiología, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
| | - Alberto Cordero
- Departamento de Cardiología, Hospital Universitario de San Juan, San Juan de Alicante, Alicante, Spain
| | - Vicente Bertomeu-Martínez
- Departamento de Cardiología, Hospital Universitario de San Juan, San Juan de Alicante, Alicante, Spain
| | - Lorenzo Fácila
- Servicio de Cardiología, Consorcio Hospital General de Valencia, Valencia, Spain
| | - Pilar Mazón
- Servicio de Cardiología, Hospital Universitario Santiago de Compostela, Santiago de Compostela, A Coruña, Spain
| | - Eduardo Alegría
- Servicio de Cardiología, Policlínica Gipuzkoa, San Sebastián, Guipúzcoa, Spain
| | | | | | | | | |
Collapse
|
8
|
Lobos Bejarano JM, Galve E, Royo-Bordonada MÁ, Alegría Ezquerra E, Armario P, Brotons Cuixart C, Camafort Babkowski M, Cordero Fort A, Maiques Galán A, Mantilla Morató T, Pérez Pérez A, Pedro-Botet J, Villar Álvarez F, González-Juanatey JR. Posicionamiento del comité español interdisciplinario de prevención cardiovascular y la sociedad española de cardiología en el tratamiento de las dislipemias. divergencia entre las guías europea y estadounidense. CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS 2015; 27:36-44. [DOI: 10.1016/j.arteri.2014.09.001] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/11/2014] [Accepted: 09/16/2014] [Indexed: 10/24/2022]
|
9
|
Brotons C, Calvo-Bonacho E, Moral I, García-Margallo MT, Cortés-Arcas MV, Puig M, Vázquez-Pirillo G, Ruilope LM. Impact of the new American and British guidelines on the management and treatment of dyslipidemia in a Spanish working population. REVISTA ESPANOLA DE CARDIOLOGIA (ENGLISH ED.) 2014; 67:906-911. [PMID: 25278212 DOI: 10.1016/j.rec.2014.06.018] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/16/2014] [Accepted: 06/25/2014] [Indexed: 06/03/2023]
Abstract
INTRODUCTION AND OBJECTIVES The guidelines of the American College of Cardiology/American Heart Association and the British National Institute for Health and Clinical Excellence on the management and treatment of dyslipidemia recommend significant changes, such as the abolition of therapeutic targets and the use of new risk tables. This study aimed to evaluate the impact of the use of these new guidelines compared with the application of European guidelines. METHODS Observational study conducted among Spanish workers. We included all workers registered with the Sociedad de Prevención de Ibermutuamur in 2011 whose cardiovascular risk could be evaluated. Cardiovascular risk was calculated for each worker using the Systematic Coronary Risk Evaluation cardiovascular risk tables for low-risk countries, as well as the tables recommended by the American and British guidelines. RESULTS A total of 258,676 workers were included (68.2% men; mean age, 39.3 years). High risk was found in 3.74% of the population according to the Systematic Coronary Risk Evaluation tables and in 6.85% and 20.83% according to the British and American tables, respectively. Treatment would be needed in 20 558 workers according to the American guidelines and in 13,222 according to the British guidelines, but in only 2612 according to the European guidelines. By following the American guidelines, the cost of statins would increase by a factor of 8. CONCLUSIONS The new recommendations would result in identifying more high-risk patients and in treating a larger fraction of the population with lipid-lowering drugs than with the European recommendations, which would result in increased costs.
Collapse
Affiliation(s)
- Carlos Brotons
- Unidad de Investigación, Equip d'Atenció Primària Sardenya, Instituto de Investigación Biomédica Sant Pau (IIB-Sant Pau), Barcelona, Spain; Unidad Docente ACEBA, Barcelona, Spain.
| | | | - Irene Moral
- Unidad de Investigación, Equip d'Atenció Primària Sardenya, Instituto de Investigación Biomédica Sant Pau (IIB-Sant Pau), Barcelona, Spain; Unidad Docente ACEBA, Barcelona, Spain
| | | | | | - Mireia Puig
- Unidad de Investigación, Equip d'Atenció Primària Sardenya, Instituto de Investigación Biomédica Sant Pau (IIB-Sant Pau), Barcelona, Spain; Unidad Docente ACEBA, Barcelona, Spain
| | - Gastón Vázquez-Pirillo
- Unidad de Investigación, Equip d'Atenció Primària Sardenya, Instituto de Investigación Biomédica Sant Pau (IIB-Sant Pau), Barcelona, Spain; Unidad Docente ACEBA, Barcelona, Spain
| | - Luis Miguel Ruilope
- Instituto de Investigación, Hospital Universitario 12 de Octubre, Madrid, Spain
| |
Collapse
|
10
|
Lobos Bejarano JM, Galve E, Royo-Bordonada MÁ, Alegría Ezquerra E, Armario P, Brotons Cuixart C, Camafort Babkowski M, Cordero Fort A, Maiques Galán A, Mantilla Morató T, Pérez Pérez A, Pedro-Botet J, Villar Álvarez F, González-Juanatey JR. Posicionamiento del Comité Español Interdisciplinario de Prevención Cardiovascular y la Sociedad Española de Cardiología en el tratamiento de las dislipemias. Divergencia entre las guías europea y estadounidense. Rev Esp Cardiol 2014. [DOI: 10.1016/j.recesp.2014.05.008] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/24/2023]
|
11
|
Impacto de las nuevas guías estadounidense y británica en el manejo y el tratamiento de las dislipemias en una población laboral española. Rev Esp Cardiol 2014. [DOI: 10.1016/j.recesp.2014.06.020] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
|
12
|
Lobos Bejarano JM, Galve E, Royo-Bordonada MÁ, Alegría Ezquerra E, Armario P, Brotons Cuixart C, Camafort Babkowski M, Cordero Fort A, Maiques Galán A, Mantilla Morató T, Pérez Pérez A, Pedro-Botet J, Villar Álvarez F, González-Juanatey JR. Spanish Interdisciplinary Committee for Cardiovascular Disease Prevention and the Spanish Society of Cardiology position statement on dyslipidemia management. Differences between the European and American guidelines. ACTA ACUST UNITED AC 2014; 67:913-9. [PMID: 25443815 DOI: 10.1016/j.rec.2014.05.008] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/24/2014] [Accepted: 05/21/2014] [Indexed: 11/24/2022]
Abstract
The publication of the 2013 American College of Cardiology/American Heart Association guidelines on the treatment of high blood cholesterol has had a strong impact due to the paradigm shift in its recommendations. The Spanish Interdisciplinary Committee for Cardiovascular Disease Prevention and the Spanish Society of Cardiology reviewed this guideline and compared it with current European guidelines on cardiovascular prevention and dyslipidemia management. The most striking aspect of the American guideline is the elimination of the low-density lipoprotein cholesterol treat-to-target strategy and the adoption of a risk reduction strategy in 4 major statin benefit groups. In patients with established cardiovascular disease, both guidelines recommend a similar therapeutic strategy (high-dose potent statins). However, in primary prevention, the application of the American guidelines would substantially increase the number of persons, particularly older people, receiving statin therapy. The elimination of the cholesterol treat-to-target strategy, so strongly rooted in the scientific community, could have a negative impact on clinical practice, create a certain amount of confusion and uncertainty among professionals, and decrease follow-up and patient adherence. Thus, this article reaffirms the recommendations of the European guidelines. Although both guidelines have positive aspects, doubt remains regarding the concerns outlined above. In addition to using risk charts based on the native population, the messages of the European guideline are more appropriate to the Spanish setting and avoid the possible risk of overtreatment with statins in primary prevention.
Collapse
Affiliation(s)
- José María Lobos Bejarano
- Comité Español Interdisciplinario de Prevención Cardiovascular, Spain; Sociedad Española de Medicina de Familia y Comunitaria, Madrid, Spain
| | - Enrique Galve
- Sección de Riesgo Vascular y Rehabilitación Cardiaca, Sociedad Española de Cardiología, Madrid, Spain.
| | - Miguel Ángel Royo-Bordonada
- Comité Español Interdisciplinario de Prevención Cardiovascular, Spain; Instituto de Salud Carlos III, Madrid, Spain
| | - Eduardo Alegría Ezquerra
- Sección de Riesgo Vascular y Rehabilitación Cardiaca, Sociedad Española de Cardiología, Madrid, Spain
| | - Pedro Armario
- Comité Español Interdisciplinario de Prevención Cardiovascular, Spain; Sociedad Española de Hipertensión-Liga Española de la Lucha Contra la Hipertensión Arterial, Madrid, Spain
| | - Carlos Brotons Cuixart
- Comité Español Interdisciplinario de Prevención Cardiovascular, Spain; Sociedad Española de Medicina de Familia y Comunitaria, Madrid, Spain
| | - Miguel Camafort Babkowski
- Comité Español Interdisciplinario de Prevención Cardiovascular, Spain; Sociedad Española de Medicina Interna, Madrid, Spain
| | - Alberto Cordero Fort
- Sección de Riesgo Vascular y Rehabilitación Cardiaca, Sociedad Española de Cardiología, Madrid, Spain
| | - Antonio Maiques Galán
- Comité Español Interdisciplinario de Prevención Cardiovascular, Spain; Programa de Actividades Preventivas y de Promoción de la Salud (PAPPS), Madrid, Spain
| | | | - Antonio Pérez Pérez
- Comité Español Interdisciplinario de Prevención Cardiovascular, Spain; Sociedad Española de Diabetes, Madrid, Spain
| | | | - Fernando Villar Álvarez
- Comité Español Interdisciplinario de Prevención Cardiovascular, Spain; Sociedad Española de Arteriosclerosis, Madrid, Spain
| | | | | | | |
Collapse
|
13
|
Anguita Sánchez M. Comentarios a la guía de práctica clínica de la ESC/ESH sobre manejo de la hipertensión arterial de la Sociedad Europea de Cardiología y la Sociedad Europea de Hipertensión 2013. Un informe del Grupo de Trabajo del Comité de Guías de Práctica Clínica de la Sociedad Española de Cardiología. Rev Esp Cardiol 2013. [DOI: 10.1016/j.recesp.2013.08.003] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
14
|
|
15
|
Galve E, Castro A, Cordero A, Dalmau R, Fácila L, García-Romero A, Mazón P, Sanmartín M, Alonso García A. Update in cardiology: Vascular risk and cardiac rehabilitation. ACTA ACUST UNITED AC 2013; 66:124-30. [PMID: 24775386 DOI: 10.1016/j.rec.2012.10.007] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/07/2012] [Accepted: 10/08/2012] [Indexed: 11/17/2022]
Abstract
Atherosclerotic cardiovascular disease remains the major cause of premature death in developed and developing countries. Nevertheless, surveys show that most patients still do not achieve the lifestyles, risk factor levels, and therapeutic targets recommended in primary and secondary prevention. The present update reflects the most recent novelties in risk classification and estimation of risk and documents the latest changes in fields such as smoking, diet and nutrition, physical activity, lipids, hypertension, diabetes, and cardiovascular rehabilitation, based on experimental trials and population-based observational studies.
Collapse
Affiliation(s)
- Enrique Galve
- Servicio de Cardiología, Hospital Vall d'Hebron, Barcelona, Spain.
| | | | - Alberto Cordero
- Departamento de Cardiología, Hospital de San Juan, San Juan de Alicante, Alicante, Spain
| | - Regina Dalmau
- Servicio de Cardiología, Hospital La Paz, Madrid, Spain
| | - Lorenzo Fácila
- Departamento de Cardiología, Hospital General de Valencia, Valencia, Spain
| | | | - Pilar Mazón
- Servicio de Cardiología, Hospital de Santiago de Compostela, Santiago de Compostela, A Coruña, Spain
| | | | | |
Collapse
|
16
|
Heras M, Avanzas P, Bayes-Genis A, de Isla LP, Sanchis J. [Current Topics in Cardiology in 2011. Introduction: developments in 2011]. Rev Esp Cardiol 2012; 65 Suppl 1:1-3. [PMID: 22379618 DOI: 10.1016/j.recesp.2011.11.014] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
|